Ozempic, Wegovy might help ease knee arthritis pain

The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after 68 weeks, compared with 3% of people given a placebo, results showed. The trial was funded by Novo Nordisk, the drug company that makes semaglutide.

Advertisement